Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/118252
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.contributorMainland Development Office-
dc.creatorChen, R-
dc.creatorZhuang, Y-
dc.creatorZhang, L-
dc.creatorWu, Y-
dc.creatorLuo, L-
dc.creatorPan, Y-
dc.creatorLi, Y-
dc.creatorZhu, C-
dc.creatorXu, R-
dc.creatorJiang, Y-
dc.creatorHao, Z-
dc.creatorTian, B-
dc.creatorZhang, L-
dc.creatorDong, Y-
dc.creatorLiu, D-
dc.date.accessioned2026-03-26T06:24:34Z-
dc.date.available2026-03-26T06:24:34Z-
dc.identifier.issn0002-7863-
dc.identifier.urihttp://hdl.handle.net/10397/118252-
dc.language.isoenen_US
dc.publisherAmerican Chemical Societyen_US
dc.titleA computationally optimized ribonucleic acid circularization strategy without byproductsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage32932-
dc.identifier.epage32940-
dc.identifier.volume147-
dc.identifier.issue36-
dc.identifier.doi10.1021/jacs.5c09798-
dcterms.abstractCircular mRNA (mRNA) exhibits promising potential in mRNA therapy due to its increased stability and extended duration of protein translation, which has sparked an urgent demand for efficient methods to prepare circular RNAs in vitro. Here, we present a versatile self-circularization strategy that employs simple motifs to synthesize circular RNAs, achieving robust efficiencies for sequences ranging from dozens to thousands of nucleotides. By leveraging an automated computational program, we optimized highly specific lock-key structures to maximize circularization efficiency, particularly for long RNA substrates. Furthermore, the shared sequence and functionality between linear precursor RNAs and circular products eliminate the need for additional purification steps to remove excess nucleic acid components, simplifying the production process. This approach also yields circular RNAs with superior stability and translation efficiency, enabling sustained protein expression in vitro and in vivo. Our computationally optimized, purification-free method holds immense promise for scalable circular RNA production and the development of advanced RNA therapeutics, significantly advancing mRNA therapy.-
dcterms.accessRightsembargoed accessen_US
dcterms.bibliographicCitationJournal of the American Chemical Society, 10 Sept 2025, v. 147, no. 36, p. 32932-32940-
dcterms.isPartOfJournal of the American Chemical Society-
dcterms.issued2025-09-10-
dc.identifier.scopus2-s2.0-105015401740-
dc.identifier.pmid40875924-
dc.identifier.eissn1520-5126-
dc.description.validate202603 bcjz-
dc.description.oaNot applicableen_US
dc.identifier.SubFormIDG001301/2026-02en_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextThis work was supported by the National Basic Research Plan of China (2023YFA0915201, 2024YFA1308500), the Beijing Municipal Science & Technology Commission (Z231100007223003), the Beijing Natural Science Foundation (JQ24007), and the National Natural Science Foundation of China (22477122).en_US
dc.description.pubStatusPublisheden_US
dc.date.embargo2026-08-28en_US
dc.description.oaCategoryGreen (AAM)en_US
Appears in Collections:Journal/Magazine Article
Open Access Information
Status embargoed access
Embargo End Date 2026-08-28
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.